ALKERMES reported 49.56M in Cost of Sales for its third fiscal quarter of 2021.


Ok
Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
width
height
Cost Of Sales Change
Abbvie ABBV:US $ 4341M 157M
Acadia Pharmaceuticals ACAD:US $ 6.68M 1.48M
Acorda Therapeutics ACOR:US $ 13.3M 1.98M
Amgen AMGN:US $ 1609M 28M
Biogen BIIB:US $ 511.8M 52.1M
Biomarin Pharmaceutical BMRN:US $ 103.54M 23.52M
Bluebird Bio BLUE:US $ 19.7M 4.4M
Bristol Myers Squibb BMY:US $ 2291M 160M
Coherus Biosciences CHRS:US $ 21.28M 4.58M
Eli Lilly And LLY:US $ 1430.8M 522.4M
Gilead Sciences GILD:US $ 1223M 167M
Gw Pharmaceuticals GWPH:US $ 11.81M 1.39M
H. Lundbeck A/S LUN:DC 851M 0
Heron Therapeutics HRTX:US $ 11.35M 3.17M
Horizon Pharma HZNP:US $ 251.64M 50.64M
Intra Cellular Therapies ITCI:US $ 2M 0.04M
IONIS PHARMACEUT IONS:US $ 3M 0.04M
JAZZ PHA JAZZ:US $ 145.22M 26.03M
Johnson & Johnson JNJ:US $ 7250M 317M
Merk MRK:US $ 3056M 14M
Nektar Therapeutics NKTR:US $ 5.31M 2.36M
Neurocrine Biosciences NBIX:US $ 4.2M 1.1M
Otsuka Holdings 4578:JP Y 123460M 1774M
Pfizer PFE:US $ 9931M 2939M
Regeneron Pharmaceuticals REGN:US $ 453.2M 240.5M
Revance Therapeutics RVNC:US $ 5.89M 460K
Teva Pharmaceutical Industries TEVA:US $ 1989M 2M
Vertex Pharmaceuticals VRTX:US $ 236.51M 8.54M
Zogenix ZGNX:US $ 1.29M 0.07M